Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Plos Medicine|February 5, 2026
Estimating the global burden of viable Mycobacterium tuberculosis infection: A mathematical modelling studyAlvaro Schwalb, Peter J Dodd, Hannah M Rickman, et al.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
Do no harm - re-evaluating the risks of overtreatment in community-wide tuberculosis screeningRein M G J Houben, Lara D Veeken, Alvaro Schwalb, et al.
The Journal of Infectious Diseases|May 23, 2025
Mind the Clinic-Community Gap: Re-evaluation of Test Performance and False Positive Results in Community-Wide Tuberculosis ScreeningLara D Veeken, Alvaro Schwalb, Katherine C Horton, et al.
Emerging Infectious Diseases|March 21, 2026
Projected Effects of Changing Global Tuberculosis Epidemiology on Mycobacterium tuberculosis Immunoreactivity Prevalence, 2024-2050Michelle Machado, Aria Ed Jordan, Alvaro Schwalb, et al.
The American Journal of Tropical Medicine and Hygiene|November 23, 2021
Zika Virus Seroprevalence in Two Districts of Chincha, Ica, Peru: A Cross-Sectional StudyRodrigo Cachay, Alvaro Schwalb, J Gonzalo Acevedo-Rodriguez, et al.
PLOS Global Public Health|March 24, 2023
Know your tuberculosis epidemic-Is it time to add Mycobacterium tuberculosis immunoreactivity back into global surveillance?Hannah M Rickman, Wala Kamchedzera, Alvaro Schwalb, et al.
Msphere|November 24, 2021
High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based StudyAndres Moreira-Soto, Johanna Maribel Pachamora Diaz, Lilian González-Auza, et al.
Pageof 4